Testosterone metabolites inhibit proliferation of castration- and therapy-resistant prostate cancer.

about

Testosterone metabolites inhibit proliferation of castration- and therapy-resistant prostate cancer.

Item

http://www.wikidata.org/entity/Q52571247

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Testosterone metabolites inhib ...... apy-resistant prostate cancer.

@en

Testosterone metabolites inhib ...... apy-resistant prostate cancer.

@nl

type

Item

label

Testosterone metabolites inhib ...... apy-resistant prostate cancer.

@en

Testosterone metabolites inhib ...... apy-resistant prostate cancer.

@nl

prefLabel

Testosterone metabolites inhib ...... apy-resistant prostate cancer.

@en

Testosterone metabolites inhib ...... apy-resistant prostate cancer.

@nl

P1476

Testosterone metabolites inhib ...... apy-resistant prostate cancer.

@en

P2093

Felix Bremmer

http://www.w3.org/2001/XMLSchema#string

Heinz-Joachim Radzun

http://www.w3.org/2001/XMLSchema#string

Hubertus Jarry

http://www.w3.org/2001/XMLSchema#string

Paul Thelen

http://www.w3.org/2001/XMLSchema#string

Peter Burfeind

http://www.w3.org/2001/XMLSchema#string

Philipp Ströbel

http://www.w3.org/2001/XMLSchema#string

Silke Kaulfuss

http://www.w3.org/2001/XMLSchema#string

Valerie Unterkircher

http://www.w3.org/2001/XMLSchema#string

P2860

An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study

Abiraterone in metastatic prostate cancer without previous chemotherapy

The relevance of estrogen receptor-beta expression to the antiproliferative effects observed with histone deacetylase inhibitors and phytoestrogens in prostate cancer treatment

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

Increased survival with enzalutamide in prostate cancer after chemotherapy

Abiraterone and increased survival in metastatic prostate cancer

Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer.

Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer

Mechanisms of estrogen action.

P304

16951-16961

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.24763

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29682196

http://www.w3.org/2001/XMLSchema#string

P932

5908297

http://www.w3.org/2001/XMLSchema#string